SUVEN
Suven Life Sciences Limited
Healthcare Research, Analytics & Technology
Share price
₹306
Market cap
₹8,639 Cr
1Y return
▲ 49%
A clinical-stage biopharmaceutical company engaged in the acquisition, development, and commercialization of novel therapeutics for treating neurodegenerative disorders. Suven Life Sciences operates across research, analytics, and technology platforms to advance its pipeline of investigational drugs targeting diseases affecting the nervous system. The company focuses on bringing innovative treatment solutions to patients suffering from neurological conditions through rigorous clinical development processes.
Investors holding Suven Life Sciences Limited
Recent moves 3
Quant Mutual FundExited
Quant Mutual Fund has dropped from Suven Life Sciences Limited's disclosed shareholder list after previously holding 1.78 percent, indicating either a complete exit or a reduction of its stake to below the 1 percent reporting requirement.
Read more
Abakkus Mutual FundDecreased
Abakkus Mutual Fund decreased its stake in Suven Life Sciences from 1.13% to 1.00%, selling 168,636 shares. The value of the sold shares is approximately ₹5.49 Cr, calculated at the last closing price of ₹325.90 apiece.
Read more
Jasti Property and Equity Holdings Private LimitedIncreased
Jasti Property and Equity Holdings Private Limited increased its stake in Suven Life Sciences from 65.40% to 69.57% by acquiring 3,17,68,764 shares for ₹437.58 Cr at ₹137.74 apiece through a preferential allotment.
Read more
Track the whales in Suven Life Sciences Limited
Get alerted the moment a top investor buys or sells.
Get started